BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25723399)

  • 21. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
    Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
    Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.
    Kawamura D; Takemoto Y; Nishimoto A; Ueno K; Hosoyama T; Shirasawa B; Tanaka T; Kugimiya N; Harada E; Hamano K
    Oncol Rep; 2017 Nov; 38(5):3238-3244. PubMed ID: 29048622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
    Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M
    PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-424 inhibits cell migration, invasion, and epithelial mesenchymal transition by downregulating doublecortin-like kinase 1 in ovarian clear cell carcinoma.
    Wu X; Ruan Y; Jiang H; Xu C
    Int J Biochem Cell Biol; 2017 Apr; 85():66-74. PubMed ID: 28161486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic DCLK1
    Qiu W; Remotti HE; Tang SM; Wang E; Dobberteen L; Lee Youssof A; Lee JH; Cheung EC; Su GH
    Cancer Lett; 2018 Jun; 423():71-79. PubMed ID: 29526803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.
    Koizumi M; Hiasa Y; Kumagi T; Yamanishi H; Azemoto N; Kobata T; Matsuura B; Abe M; Onji M
    PLoS One; 2013; 8(8):e71367. PubMed ID: 23940742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
    Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
    Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a selective inhibitor of doublecortin like kinase 1.
    Ferguson FM; Nabet B; Raghavan S; Liu Y; Leggett AL; Kuljanin M; Kalekar RL; Yang A; He S; Wang J; Ng RWS; Sulahian R; Li L; Poulin EJ; Huang L; Koren J; Dieguez-Martinez N; Espinosa S; Zeng Z; Corona CR; Vasta JD; Ohi R; Sim T; Kim ND; Harshbarger W; Lizcano JM; Robers MB; Muthaswamy S; Lin CY; Look AT; Haigis KM; Mancias JD; Wolpin BM; Aguirre AJ; Hahn WC; Westover KD; Gray NS
    Nat Chem Biol; 2020 Jun; 16(6):635-643. PubMed ID: 32251410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of stromal activin A in human pancreatic cancer and metastasis in mice.
    Mancinelli G; Torres C; Krett N; Bauer J; Castellanos K; McKinney R; Dawson D; Guzman G; Hwang R; Grimaldo S; Grippo P; Jung B
    Sci Rep; 2021 Apr; 11(1):7986. PubMed ID: 33846512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases.
    Moore LL; Qu D; Sureban S; Mitchell S; Pitts K; Cooper N; Fazili J; Harty R; Oseini A; Ding K; Bronze M; Houchen CW
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1.
    Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW
    Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation.
    Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R
    Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.
    Chandrakesan P; Weygant N; May R; Qu D; Chinthalapally HR; Sureban SM; Ali N; Lightfoot SA; Umar S; Houchen CW
    Oncotarget; 2014 Oct; 5(19):9269-80. PubMed ID: 25211188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
    Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP
    Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.